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Increasing energy expenditure via induction of adipose tissue browning has become an
appealing strategy to treat obesity and associated metabolic complications. Herein, we
identify adipocyte-expressed apoptosis signal-regulating kinase 1 (ASK1) as regulator of
adipose tissue browning. High fat diet-fed adipocyte-specific ASK1 knockout mice reveal
increased UCP1 protein levels in inguinal adipose tissue concomitant with elevated energy
expenditure, reduced obesity and ameliorated glucose tolerance compared to control litter-
mates. In addition, ASK1-depletion blunts LPS-mediated downregulation of isoproterenol-
induced UCP1 in subcutaneous fat both in vitro and in vivo. Conversely, adipocyte-specific
ASK1 overexpression in chow-fed mice attenuates cold-induced UCP1 protein levels in
inguinal fat. Mechanistically, ASK1 phosphorylates interferon regulatory factor 3 (IRF3)
resulting in reduced Ucp1 expression. Taken together, our studies unravel a role of ASK1 in
mediating the inhibitory effect of caloric surplus or LPS-treatment on adipose tissue
browning. Adipocyte ASK1 might be a pharmacological target to combat obesity and asso-
ciated morbidities.
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issipation of energy in brown adipose tissue (BAT) has
emerged as a promising target to combat obesity and
associated co-morbidities1–4. It depends on uncoupling
protein 1 (UCP1)-mediated proton leak across the inner mito-
chondrial membrane leading to heat production5. Besides BAT,
beige adipocytes residing in white adipose tissue (WAT) can
express UCP1, and its expression is induced by β3-adrenergic
receptor stimulation leading to browning of WAT6. Given the
fact that adult humans have little or no existing active BAT,
selective induction of WAT browning rather than activation of
BAT is thought to have therapeutic potential to counteract the
obesity pandemic7,8. However, while many factors affecting
browning of WAT have been described in rodents, only very few
revealed a selective effect constrained to WAT9.
Obesity is associated with a chronic low-grade inflammation of
adipose tissue characterized by elevated local and circulating
levels of pro-inflammatory cytokines and endotoxins10,11. Inter-
estingly, recent reports suggest that these inflammatory factors
may negatively affect browning of WAT. In fact, the pro-
inflammatory cytokine tumor necrosis factor-alpha (TNFα) and
the endotoxin lipopolysaccharide (LPS), which are both elevated
in circulation as well as in adipose tissue under obesity12–15,
reduced UCP1 levels in adipocytes16–18.
Strikingly, TNFα as well as LPS are activators of the apoptosis
signal-regulating kinase 1 (ASK1)4,19,20. In fact, ASK1 is specifi-
cally activated by LPS and selectively required for
TLR4 signaling19. ASK1 is a family member of the mitogen-
activated protein kinase kinase kinase (MAP3K)21, acting as a
signaling node in which different stressors such as endoplasmic
reticulum, oxidative and inflammatory stresses converge4. In
addition to being activated by different stressors, ASK1 signaling
can be induced via autophosphorylation22 suggesting that a mere
increase in ASK1 expression results in elevated ASK1 activity.
Importantly, elevated ASK1 expression in adipose tissue of obese
human subjects was found to be an independent predictor of
whole-body insulin resistance23, underscoring the potential
importance of this stress-signaling pathway in obesity and asso-
ciated metabolic disorders. Herein, we hypothesize that obesity-
induced expression/activation of ASK1 in adipocytes negatively
affects UCP1 protein expression in WAT thereby mediating an
inhibitory effect on adipose tissue browning.
Results
LPS treatment blunts Ucp1 expression in subcutaneous adi-
pocytes ASK1-dependently. Activation of the TLR4 pathway via
chronic injection of LPS decreased cold-induced expression of
UCP1 in subcutaneous WAT of C57BL/6 mice16. In line, we
found that chronic LPS administration using osmotic mini-
pumps significantly reduced UCP1 protein levels in inguinal
WAT of C57BL/6 mice that were cold-exposed for 7 days (Fig. 1a,
b), a condition previously shown to induce browning of WAT
in vivo24. In addition, LPS treatment blunted β3-adrenoreceptor
agonist-induced Ucp1 mRNA expression in inguinal fat explants
harvested from lean C57BL/6 mice (Fig. 1c), further supporting a
negative impact of LPS on the thermogenic potential of WAT. To
elucidate the molecular mechanism, experiments in immortalized
pre-adipocytes derived from murine subcutaneous WAT25 were
performed. As expected, treatment of mature subcutaneous (sc)
white adipocytes with the β3-adrenoreceptor agonist iso-
proterenol increased Ucp1 mRNA expression levels (>100 fold)
compared to untreated control cells (Supplementary Fig. 1a)
indicating a high browning capacity of these cells. Similar to the
effect in inguinal fat explants (Fig. 1c), pre-treatment of sub-
cutaneous white adipocytes with LPS significantly reduced
isoproterenol-induced Ucp1 expression by ~50 % (Fig. 1d)
suggesting that such cells may be a valid model to investigate
molecular mechanisms involved in LPS-induced inhibition of
browning.
As outlined above, ASK1 is an important signaling node
downstream of LPS as well as other mediators and might be
involved in the suppression of obesity-induced WAT brown-
ing17–19,26. Of note, ASK1 levels in adipose tissue were increased
in obesity23 suggesting that elevated ASK1 expression may
negatively affect UCP1 levels in adipose tissue. In line with this
human data, we found significantly elevated ASK1 protein levels
in inguinal adipose tissue of C57BL/6 mice fed a high-fat diet
(HFD) compared to chow-fed control mice (Fig. 1e, f). In parallel,
phosphorylated levels of ASK1 (Thr845) were significantly
elevated in HFD-fed mice, indicating increased activation of
ASK1 in the latter (Supplementary Fig. 1b). Moreover, treatment
of subcutaneous white adipocytes with LPS increased Ask1
expression (Fig. 1g) similar to effects induced by TNFα, Fas
ligand or oxidative stress26. Besides, LPS significantly induced
phosphorylation of ASK1 in subcutaneous adipocytes as well as in
inguinal WAT of C57BL/6 mice receiving chronic LPS admin-
istration using osmotic mini-pumps (Supplementary Fig. 1c, d).
To test whether ASK1 may mediate LPS-induced blunting of
Ucp1 expression (Fig. 1d), we generated a lentiviral construct
expressing a short hairpin RNA (shRNA) against ASK1 (shASK1)
to knockdown ASK1 in subcutaneous adipocytes. As intended,
expression of Ask1 was significantly reduced in shASK1
transfected cells when compared to shLuc transfected control
cells (Supplementary Fig. 1e). Strikingly, ASK1 knockdown
significantly blunted LPS-induced Ucp1 downregulation (Fig. 1h),
whereas shLuc transfected subcutaneous white adipocytes showed
a similar degree of LPS-mediated reduction of Ucp1 mRNA
expression compared to non-transfected cells (Fig. 1d). These
results indicate that ASK1 is involved in the control of Ucp1
expression in subcutaneous adipocytes and, hence, may be a
modulator of adipose tissue browning and, consequently, obesity.
Reduced body weight and improved glucose tolerance in HFD-
fed ASK1Δadipo mice. To investigate whether depletion of
adipocyte-expressed ASK1 affects browning and obesity, we
generated adipocyte-specific ASK1 knockout mice (ASK1Δadipo)
on a C57BL/6 background using the Cre-lox system. As shown in
the gene targeting design (Supplementary Fig. 2a), exon 14 of
ASK1 (whose deletion leads to a frameshift) is removed in these
mice upon Cre-recombinase (Cre) expression. As controls, lit-
termate mice with floxed ASK1 but lacking Cre expression under
the adiponectin promotor were used (ASK1F/F). Adipocyte-
specific deletion of ASK1 was confirmed by western blot analysis
(Fig. 2a). As expected, we detected reduced ASK1 protein levels in
BAT due to adiponectin expression in this tissue, while similar
ASK1 protein levels were found in muscle, brain and liver
(Supplementary Fig. 2b). In order to investigate the physiological
significance of adipocyte-specific ASK1 depletion, mice were fed
either a standard chow or HFD for 12 weeks. While body weight
and weight gain was not affected in chow-fed mice (Fig. 2b, c),
ASK1Δadipo mice fed a HFD revealed significantly reduced weight
gain resulting in lower body weight compared to control litter-
mates (Fig. 2b, c). Next, glucose tolerance tests were performed to
assess whether adipocyte-specific depletion of ASK1 affected
glucose metabolism. As expected, 12 weeks of HFD significantly
deteriorated glucose tolerance in ASK1F/F mice compared to
chow-fed mice (Fig. 2d, e). Importantly, glucose tolerance was
significantly improved in HFD-fed ASK1Δadipo compared to
control littermates (Fig. 2d, e). We used a short-term, 4 days HFD
paradigm to differentiate between the effect of ASK1 deletion in
adipocytes on weight from its effect on glucose tolerance. Even
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with no body weight difference after 4 days of HFD between the
two groups (ASK1F/F: 21.6 ± 0.7 g vs. ASK1Δadipo: 21.2 ± 0.5 g;
p= 0.67), glucose tolerance was improved in ASK1Δadipo (Sup-
plementary Fig. 2c). Hence, depletion of ASK1 positively affects
glucose metabolism independent of body mass under HFD con-
ditions. In addition, circulating insulin levels were significantly
reduced in HFD-fed knockout mice (Supplementary Table 1)
indicating improved insulin sensitivity. To investigate the latter,
hyperinsulinemic-euglycemic clamp studies were performed. A
significantly increased glucose infusion rate in HFD-fed
ASK1Δadipo compared to ASK1F/F mice was noted, consistent
with improved whole-body insulin sensitivity (Fig. 2f and Sup-
plementary Fig. 2d, e). Glucose uptake during clamp was sig-
nificantly increased into inguinal and trend wise higher into
epididymal adipose tissue of HFD-fed ASK1Δadipo compared to
ASK1F/F mice. By contrast, glucose uptake into BAT and skeletal
muscle was similar between both genotypes (Fig. 2g). Of note,
endogenous glucose production under hyperinsulinemic clamp
conditions was significantly reduced in ASK1Δadipo compared to
control littermates indicating blunted hepatic insulin resistance
(Fig. 2h). The latter is closely associated with visceral adipose
tissue inflammation and liver steatosis27. As shown in Fig. 2i,
HFD-fed ASK1Δadipo mice revealed significantly reduced hepatic
steatosis as determined by liver triglyceride accumulation. How-
ever, the degree of mesenteric fat inflammation, as assessed by
mRNA expression of inflammatory markers such as Tnfα, Il-6,
Mcp1, and Il-1β, did not significantly differ between the two
genotypes (Fig. 2j). Moreover, expression of the anti-
inflammatory cytokine Il-10 and the macrophage marker F4/80
were unchanged (Fig. 2j). In line, we found a similar degree of
inflammation in inguinal adipose tissue of HFD-fed knockout
and control mice (Supplementary Fig. 2f). In accordance, circu-
lating levels of TNFα, IL-6, IL-10, IFN-γ and KC were compar-
able (Supplementary Table 1) suggesting a similar degree of
adipose tissue inflammation in HFD-fed ASK1Δadipo and ASK1F/F
mice.
Both adipocytes as well as the stromal vascular fraction, albeit
to a lower degree, contributed to increased ASK1 expression in
adipose tissue of obese human subjects23. Consequently, ASK1
activation in adipocytes as well as myeloid cells may play a role in
obesity-induced metabolic complications. To investigate the
contribution of myeloid cell-expressed ASK1 to the development
of obesity and glucose intolerance, we generated myeloid cell-
specific ASK1 knockout mice (ASK1flox/flox, Lysozyme-cre+/−;
ASK1Δmye) using the Cre-lox system. Such Cre-mediated
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Fig. 1 LPS treatment blunts UCP1 expression in subcutaneous adipocytes ASK1-dependently. a, b Western blot and quantified protein levels of UCP1 in
total lysates of inguinal white adipose tissue harvested from cold-exposed C57BL/6J mice chronically treated with or without LPS. n= 3 mice per group.
**p= 0.004. c Ucp1 mRNA expression in inguinal fat explants harvested from C57BL/6J mice were treated with or without 100 ng/ml LPS and
subsequently with 10 µM isoproterenol for 8 h. n= 3 biological replicates. *p= 0.036. d Ucp1 mRNA expression in subcutaneous adipocytes pre-treated
with or without 100 ng/ml LPS for 24 h followed by stimulation with 0.1 µM isoproterenol for 6 h. n= 7 (LPS) or n= 8 (control) biological replicates. **p=
0.007. e, fWestern blot and quantified protein levels of ASK1 in total lysates of inguinal white adipose tissue harvested from C57BL/6J mice fed a chow or
HFD for 20 weeks. n= 8 (chow) and n= 7 (HFD) mice per group. *p= 0.037. g Ask1mRNA expression in subcutaneous adipocytes treated with or without
100 ng/ml LPS treatment for 24 h. n= 7 biological replicates. *p= 0.046. h Ucp1 mRNA expression in subcutaneous adipocytes transfected with control
shRNA lentivirus (shLuc) or shRNA lentivirus targeting ASK1 (shASK1) pre-treated with 100 ng/ml LPS for 24 h followed by stimulation with 0.1 µM
isoproterenol for 6 h. n= 11 (shASK1 control and shLuc LPS) or n= 12 (shASK1 LPS and shLuc control) biological replicates. *p= 0.027. Values are
expressed as mean ± SEM. Statistical tests used: two-sided t-tests for (b–d, f–h). Source data are provided as a Source Data file.
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Fig. 2 Reduced body weight and improved glucose tolerance in HFD-fed ASK1Δadipo mice. a Protein levels of ASK1 in lysate of isolated epididymal
adipocytes harvested from ASK1F/F and ASK1Δadipo mice (n= 3 mice per group). b, c Body weight and body weight gain during 12 weeks of chow (ASK1F/F,
n= 20 mice; ASK1∆adipo, n= 13 mice) or HFD feeding (ASK1F/F, n= 52 mice; ASK1∆adipo, n= 58 mice). **p= 0.02, ***p < 0.001. d, e Intraperitoneal
glucose-tolerance test (chow-fed: ASK1F/F, n= 10 mice; ASK1∆adipo, n= 8 mice; HFD-fed: ASK1F/F, n= 13 mice; ASK1∆adipo, n= 14 mice) at 18 weeks of
age. **p= 0.03, ***p < 0.001. f Glucose infusion rate (GIR) during hyperinsulinemic-euglycemic clamps in HFD-fed ASK1F/F (n= 6) and ASK1∆adipo (n= 8)
mice. *p= 0.011. g Glucose uptake into respective tissues during hyperinsulinemic-euglycemic clamps in HFD-fed ASK1F/F (n= 5 (ing WAT, epiWAT and
skeletal muscle) or n= 6 (BAT)) and ASK1∆adipo (n= 4 (BAT), n= 6 (ingWAT) or n= 7 (epiWAT and skeletal muscle)) mice. *p= 0.034, #p= 0.062.
h Endogenous glucose production (EGP) during hyperinsulinemic-euglycemic clamps in HFD-fed ASK1F/F (n= 6) and ASK1∆adipo (n= 8) mice. *p= 0.040.
i Liver triglyceride levels determined in HFD-fed ASK1F/F (n= 6) and ASK1∆adipo (n= 6) mice. *p= 0.012. jMesenteric adipose tissue mRNA expression of
respective targets determined in HFD-fed ASK1F/F (n= 5 (Il-10, F4/80) or n= 8 (TNFα, Il-6, Mcp1, Il-1β) and ASK1∆adipo (n= 7 (Il-10, F4/80) or n= 9
(TNFα, Il-6, Mcp1, Il-1β)) mice. Values are expressed as mean ± SEM. Statistical tests used: two-sided t-tests for (f, g) (without adjustments for multiple
comparisons), h, i ANOVA for (b–e). AUC: area under the curve. Source data are provided as a Source Data file.
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cells including monocytes, mature macrophages, microglia and
granulocytes28. Deletion of ASK1 in macrophages was confirmed
by western blot analysis. By contrast, similar ASK1 protein levels
were retained in spleen and liver (Supplementary Fig. 3a). We
detected slightly reduced ASK1 protein levels in brain, WAT and
BAT, which may be explained by the presence of resident
myeloid-derived immune cells in these organs, such as microglia
in the brain and monocytes and macrophages in BAT and WAT.
To test the physiological significance of myeloid cell-specific
ASK1 depletion, ASK1F/F and ASK1Δmye mice were fed either a
chow or a HFD for 20 weeks. As expected, HFD-fed mice
revealed significantly higher body weight and impaired glucose
tolerance compared to chow-fed mice. Regardless of diets, no
difference in body weight and amount of body fat was found
between both genotypes (Supplementary Fig. 3b, c). Similarly,
myeloid-specific ASK1 knockdown affected neither glucose
tolerance nor insulin sensitivity in both diet groups (Supplemen-
tary Fig. 3d, e). Taken together, targeted genetic disruption of
ASK1 signaling in adipocytes, but not in myeloid cells, elicits
beneficial effects on obesity and obesity-induced insulin
resistance.
Increased heat production in HFD-fed ASK1Δadipo mice. Next,
we aimed to elaborate on the mechanisms contributing to blunted
body weight gain in HFD-fed ASK1Δadipo mice (Fig. 2b, c).
Importantly, the lean phenotype in ASK1Δadipo mice was neither
attributable to reduced food consumption nor to increased
locomotor activity (Supplementary Fig. 4a, b). In addition, it does
not result from impaired intestinal nutrient absorption capacity
since fecal caloric content was rather decreased in knockout mice,
suggesting an increased energy absorption (Supplementary
Fig. 4c). However, we found a significant increase in oxygen
consumption rate at room temperature (RT) during both light
and dark phase in adipocyte-specific ASK1 deficient mice
(Fig. 3a). Of note, such housing temperature may trigger
browning of adipose tissue as it induces chronic thermal stress
inducing fuel consumption29. Besides browning, elevated heat
loss due to fur disruption may affect energy expenditure at RT30.
Therefore, indirect calorimetry was assessed under thermoneutral
conditions, which also revealed similar difference in oxygen
consumption between HFD-fed control and knockout mice as
observed under RT (Fig. 3b), indicating absence of fur disruption
in knockout mice. As the influence of activated BAT on energy
expenditure may be negligible under thermoneutral conditions,
this finding further suggests that browning of adipose tissue may
be crucially involved in the observed phenotype. In line with
increased oxygen consumption, heat production (Fig. 3c) as well
as rectal temperature (Fig. 3d) were elevated HFD-fed ASK1Δadipo
mice.
Increased adipose tissue browning in HFD-fed ASK1Δadipo
mice. Analysis of adipose tissue mass at necropsy revealed sig-
nificantly lower WAT (inguinal, epididymal, mesenteric, and
retroperitoneal) as well as BAT fat pad weights in HFD-fed
ASK1Δadipo mice compared to control littermates (Fig. 4a and
Supplementary Fig. 4d) leading to a ~30% reduction of whole-
body fat content in ASK1Δadipo mice (Fig. 4b). Increased heat
production/energy expenditure may suggest activation of BAT or
browning of WAT in HFD-fed ASK1Δadipo mice. Macro-
scopically, inguinal WAT appeared darker in ASK1Δadipo com-
pared to ASK1F/F mice (Fig. 4c), and immunohistochemical
analysis revealed increased positive UCP1 staining in inguinal
WAT of knockout mice (Fig. 4d) suggesting increased browning.
Moreover, mRNA expression of Ucp1 and other browning mar-
kers in WAT7 such as Cidea, Pgc1α, and Prdm16 were elevated in
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Fig. 3 Increased heat production in HFD-fed ASK1Δadipo mice. a Light (day) and dark (night) oxygen consumption in HFD-fed ASK1F/F (n= 8) and
ASK1Δadipo (n= 11) mice during a 24-h period at RT. **p= 0.020 (light), **p= 0.010 (dark). b Light (day) and dark (night) oxygen consumption in HFD-fed
ASK1F/F (n= 7) and ASK1Δadipo (n= 6) mice during a 24-h period after 20 days housing at thermoneutrality. #p= 0.073, *p= 0.042. c Light (day) and
dark (night) heat production in HFD-fed ASK1F/F (n= 8) and ASK1Δadipo (n= 11) mice during a 24-h period at RT. **p= 0.009. d Rectal temperature
measured in HFD-fed ASK1F/F (n= 7) and ASK1Δadipo (n= 7) mice. *p= 0.015. Values are expressed as mean ± SEM. Statistical tests used: two-sided
t-tests for (a–d). Source data are provided as a Source Data file.
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western blot analysis of inguinal fat revealed significant
higher proteins level of UCP1 and PGC1α in HFD-fed ASK1Δa-
dipo compared to ASK1F/F mice (Fig. 4f, g). By contrast, no dif-
ferences in mRNA expression and protein levels of UCP1 and
Cidea were detected in classical BAT (Supplementary Fig. 4e, f).
Thus, targeted deletion of ASK1 in adipocytes induces browning
of WAT. By contrast, BAT UCP1 protein levels were similar
between the two genotypes indicating that ASK1 depletion
may not affect thermogenic potential of classical BAT (Supple-
mentary Fig. 4f).
As shown above (Fig. 1a, b), chronic LPS administration
reduced UCP1 protein levels in inguinal adipose tissue of cold-
exposed C57BL/6 mice. In order to test a potential involvement of
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Fig. 4 Increased adipose tissue browning in HFD-fed ASK1Δadipo mice. a, b Fat pad mass as well as total body fat mass (chow-fed: ASK1F/F, n= 13;
ASK1∆adipo, n= 10; HFD-fed: ASK1F/F, n= 10; ASK1∆adipo, n= 16) in mice at 18 weeks of age. **p= 0.005; ***p < 0.001. c Representative image of inguinal
adipose tissue of a HFD-fed ASK1F/F and ASK1∆adipo mouse (scale bar: 10mm). d Representative immunohistochemistry for UCP1 in inguinal adipose
tissue of a HFD-fed ASK1F/F (n= 3 mice) and ASK1∆adipo mouse (n= 3 mice) (scale bar: 50 µm). e mRNA expression of respective genes in inguinal
adipose tissue of HFD-fed ASK1F/F (n= 8) and ASK1Δadipo (n= 9) mice. *p= 0.027 (Ucp1), *p= 0.028 (Cidea). f, g Representative western blot and
quantification of UCP1 and PGC1α protein levels in inguinal adipose tissue harvested from HFD-fed ASK1F/F (n= 8) and ASK1Δadipo (n= 10) mice. *p=
0.031 (Ucp1), *p= 0.015 (Cidea). h, i Representative western blot and quantified protein levels of UCP1 in total lysates of inguinal white adipose tissue
harvested from cold-exposed mice chronically treated with or without LPS (saline ASK1F/F, n= 6 mice; saline ASK1∆adipo, n= 5 mice; LPS ASK1F/F, n= 7
mice; LPS ASK1∆adipo, n= 6 mice). **p= 0.003. Values are expressed as mean ± SEM. Statistical tests used: two-sided t-tests for, e (Cidea), i two-sided
Mann–Whitney for e (UCP1), g ANOVA for (a and b). Source data are provided as a Source Data file.
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mini-pumps releasing either LPS or saline were implanted into
ASK1F/F and ASK1Δadipo littermate mice. Thereafter, mice were
cold-exposed for 7 days to trigger browning of WAT24. As
intended, plasma endotoxin levels in LPS-treated ASK1F/F and
ASK1Δadipo mice were similar between the two groups but
significantly elevated compared to saline-treated mice (Supple-
mentary Fig. 4g). While LPS-treatment significantly reduced
UCP1 protein levels in cold-exposed ASK1F/F mice, UCP1
protein content was maintained in LPS-treated ASK1Δadipo mice
(Fig. 4h, i). Of note, UCP1 protein levels were not affected in
untreated cold-exposed chow-fed ASK1Δadipo mice (Supplemen-
tary Fig. 4h). Hence, disruption of ASK1 signaling in (inguinal)
adipocytes prevents LPS-mediated downregulation of cold-
induced UCP1 protein levels.
Adipocyte-specific ASK1 overexpression decreases adipose tis-
sue browning. To further investigate a regulatory role of ASK1 in
browning of WAT, mice with adipocyte-specific overexpression
of ASK1 were generated (CAG-ASK1+adipo). After Cre-lox
mediated excision of the stop cassette, such mice express ASK1
under the ubiquitous beta actin promoter CAG31. Accordingly,
adiponectin promoter-driven Cre expression promoted over-
expression of ASK1 in white adipocytes (Fig. 5a). Similarly, ASK1
protein levels were increased in BAT whereas ASK1 protein
expression was not affected in muscle, brain and liver of CAG-
ASK1+adipo compared to control littermates (CAG-ASK1F/F)
(Supplementary Fig. 5a). In parallel to increased ASK1 protein
levels, phosphorylated levels of ASK1 (Thr 845) were increased in
inguinal adipose tissue of CAG-ASK1+adipo mice indicating
increased activation of ASK1 (Supplementary Fig. 5b). To induce
browning of WAT, chow-fed CAG-ASK1+adipo and littermate
CAG-ASK1F/F mice were cold-exposed for 7 days24. Importantly,
adipocyte-specific ASK1 overexpression resulted in reduced
expression of the browning markers Ucp1, Cidea and Pgc1α in
inguinal adipose tissue (Fig. 5b). In line, protein levels of UCP1
were reduced in inguinal WAT of cold-exposed CAG-ASK1+adipo
compared to control mice (Fig. 5c, d). By contrast, BAT UCP1
protein levels did not significantly differ between CAG-ASK1F/F
and CAG-ASK1+adipo mice (Supplementary Fig. 5c, d), further
supporting the notion that ASK1 signaling affects UCP1 protein
levels in WAT but not in BAT.
ASK1 phosphorylates IRF3 thereby reducing Ucp1 expression.
Next, we aimed to investigate how ASK1 reduces Ucp1 expression
in white adipocytes. Interestingly, ASK1 is required for LPS-
mediated phosphorylation and subsequent nuclear translocation
of the transcription factor interferon regulatory factor 3 (IRF3)32.
Moreover, overexpression of IRF3 has been shown to reduce
Ucp1 expression in adipocytes33, indicating that ASK1-mediated
phosphorylation of IRF3 might decrease Ucp1 expression. Indeed,
phosphorylation of IRF3 was significantly reduced in isolated
adipocytes of ASK1Δadipo mice (Fig. 6a, b). To test whether ASK1
can directly phosphorylate IRF3, we performed an in vitro kinase
assay. Indeed, active ASK1 phosphorylated IRF3 in vitro (Fig. 6c,
d). Moreover, overexpression of wild-type ASK1 in subcutaneous
adipocytes increased IRF3 phosphorylation compared to cells
expressing kinase-negative ASK1 (Fig. 6e, f). Next, the role of
siRNA-mediated ASK1 knock down on LPS-induced IRF3
phosphorylation was assessed. As intended, ASK1 protein levels
were significantly reduced in subcutaneous adipocytes treated
with siRNAs targeting ASK1 (Supplementary Fig. 6a). Impor-
tantly, LPS-induced IRF3 phosphorylation was significantly
blunted in ASK1-depleted adipocytes (Fig. 6g, h) further indi-
cating a contribution of ASK1 to IRF3 phosphorylation. To
investigate whether IRF3 is involved in the LPS-mediated
downregulation of Ucp1 expression in adipocytes (Fig. 1d, h),
we generated a lentiviral construct expressing a short hairpin
RNA (shRNA) against IRF3 (shIRF) to knockdown IRF3 in
subcutaneous adipocytes. As expected, expression of IRF3 was


































































































Fig. 5 Adipocyte-specific ASK1 overexpression decreases adipose tissue browning. a Protein levels of ASK1 in lysate of isolated adipocytes harvested
from CAG-ASK1F/F and CAG-ASK1+adipo mice (n= 2 mice per group). b mRNA expression of respective genes in inguinal adipose tissue of cold-exposed
CAG-ASK1F/F (n= 5) and CAG-ASK1+adipo (n= 6) mice. #p= 0.094, *p= 0.042, *p= 0.017. c, d Representative western blot and quantification of UCP1
protein levels in inguinal adipose tissue harvested from cold-exposed CAG-ASK1F/F (n= 7) and CAG-ASK1+adipo (n= 8) mice. *p= 0.037. Values are
expressed as mean ± SEM. Statistical tests used: two-sided t-tests for (b) (Ucp1 and Pgc1α), d two-sided Mann–Whitney for (b) (Cidea). Source data are
provided as a Source Data file.
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to shLuc transfected control cells (Supplementary Fig. 6b).
Importantly, IRF3 knockdown significantly blunted LPS-
mediated downregulation of Ucp1 expression (Fig. 6i). Similar
results were obtained in subcutaneous adipocytes after transfec-
tion with siRNAs targeting Irf3 (Supplementary Fig. 6c, d). Such
data further confirm the notion that IRF3 is involved in the
control of Ucp1 expression in adipocytes.
Discussion
Browning of WAT significantly contributes to whole-body energy
expenditure34. Accordingly, identification of molecular pathways
that modulate browning has gained high interest since they may
serve as pharmacological target to counteract obesity and asso-
ciated metabolic disorders. Herein, we provide evidence that
adipocyte-expressed ASK1 is a negative modulator of WAT
browning in obesity thereby affecting energy expenditure, body
mass and glucose metabolism. In fact, ASK1 levels were elevated
in subcutaneous (inguinal) adipose tissue of HFD compared to
chow-fed mice, and HFD-fed mice with adipocyte-specific ASK1
depletion depicted increased browning of inguinal WAT as well
as increased energy expenditure, reduced body weight, blunted
liver steatosis and improved glucose metabolism. In support of a
regulatory role of ASK1 in adipose tissue browning, adipocyte-
specific ASK1 overexpression blunted cold-induced browning of
inguinal adipose tissue in chow-fed mice.
Physiologically, increased energy consumption stimulates
thermogenesis in brown and/or beige adipocytes via activation of
the sympathetic nervous system and/or via secretion of humoral
factors35,36. Accordingly, high calorie intake may trigger a com-
pensatory adaptation leading to increased energy expenditure,
thereby preventing diet-induced obesity. However, diet-induced
thermogenesis is unchanged or even blunted in obesity37 indi-
cating that such compensation may be disturbed under obese
condition. Accordingly, identification of targets that block diet-
induced thermogenesis in obesity is of great importance. In this
regard, PPARγ expression in neurons was identified as a “brake”
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Fig. 6 ASK1 phosphorylates IRF3. a, b Representative western blot and quantification of pIRF3 protein levels in isolated adipocytes of HFD-fed ASK1F/F and
ASK1Δadipo mice. n= 6 mice per group. *p= 0.048. c, d Representative western blot and quantification of pIRF3 upon incubation of recombinant IRF3 with
or without active ASK1. n= 6 biological replicates. ***p= 0.0006. e, f Western blot and quantification of pIRF3 protein levels in subcutaneous adipocytes
transfected with lentivirus expressing wild-type (pLV-CMV-ASK1; ASK1 wt) or kinase-negative (pLV-CMV-ASK1-K716R; ASK1 mut) ASK1. n= 3 biological
replicates. #p= 0.070. g, h Representative western blot and quantification of pIRF3 protein levels in subcutaneous adipocytes transfected with control
siRNA (Co siRNA) or siRNA targeting ASK1 (ASK1 siRNA) treated with or without 100 ng/ml LPS for 6 h. n= 4 biological replicates. ****p < 0.0001. i Ucp1
mRNA expression in subcutaneous adipocytes transfected with control shRNA lentivirus (shLuc) or shRNA lentivirus targeting IRF3 (shIRF3) pre-treated
with 100 ng/ml LPS for 24 h followed by stimulation with 0.1 µM isoproterenol for 6 h. n= 6 biological replicates. *p= 0.019. Values are expressed as
mean ± SEM. Statistical tests used: two-sided t-tests for (b, d, f, i), two-sided one sample t-test for (h). Source data are provided as a Source Data file.
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deletion in vagal neurons promoted HFD-induced thermogenesis
and reduced body weight gain in mice38. Similarly, our results
suggest that increased ASK1 expression in adipocytes during
obesity may act as a “brake” inhibiting diet-induced browning of
WAT. What are potential factors inducing ASK1 in adipocytes?
Importantly, ASK1 in adipocytes is induced in response to dif-
ferent stimuli and stressors such as TNFα, Fas ligand or the
enzyme glucose oxidase, which induces oxidative stress26.
Moreover, we present herein evidence that the gut microbiota-
derived endotoxin LPS induces ASK1 in adipocytes. In obesity,
aforementioned stressors and stimuli are all elevated in adipose
tissue13–15,39,40 promoting ASK1 expression in adipocytes. Of
note, activation of ASK1 may be needed to mediate its negative
effect on browning. In fact, UCP1 levels were not altered in
ASK1-depleted chow-fed mice, whereas they were affected in
HFD-fed or LPS-administered ASK1-depleted mice. Importantly,
both interventions (HFD-feeding, LPS administration) increased
ASK1 phosphorylation/activation. In line, reduced UCP1 protein
levels in cold-exposed CAG-ASK1+adipo mice were paralleled by
increased levels of phosphorylated ASK1.
Our finding of increased ASK1 protein levels in inguinal WAT
of HFD mice is in line with a previous report revealing increased
expression of ASK1 in adipose tissue of obese subjects23. The
increased ASK1 expression was suggested to contribute to ele-
vated adipose tissue inflammation and, consequently, to obesity-
induced metabolic disorders23,26. While we only observed a slight
reduction in adipose tissue inflammation in HFD-fed ASK1Δadipo
mice, we cannot rule out that such difference contributed to the
observed phenotype, i.e., to reduced hepatic insulin resistance and
lipid accumulation. However, reduced liver lipid accumulation in
knockout mice more likely resulted from increased consumption
of fatty acids to sustain elevated thermogenesis induced by WAT
browning and, thus, decreased ectopic lipid deposition41. In turn,
reduced hepatic steatosis may lead to blunted liver insulin resis-
tance42. ASK1 expression in adipose tissue of obese human
subjects was not only increased in adipocytes, but also in the
stromal vascular fraction, which comprises of macrophages
among other cells23. However, we found no effect of myeloid-
specific ASK1 depletion on body weight gain and glucose meta-
bolism, suggesting that increased ASK1 expression rather in
adipocytes than in macrophages impairs glucose and energy
homeostasis in obesity.
Intriguingly, gain and loss of function of ASK1 in adipocytes
affected UCP1 protein levels in WAT but not in BAT indicating
that ASK1 regulates adipose tissue browning without affecting the
thermogenic potential of classical BAT. In further support of such
notion, glucose uptake during clamps studies was affected in
inguinal WAT but no in BAT of HFD-fed ASK1Δadipo mice. Such
finding is in line with other studies reporting specific effects of
genetic manipulation (overexpression of Prdm16, deletion
of Notch, deletion of the MAPK kinase 6 (MKK6), deletion of
Laminin α4 (LAMA4)) on WAT browning without affecting BAT
function43–46. Similarly, HFD-fed IRF3 deficient mice revealed
elevated WAT browning compared to control mice, whereas
expression of thermogenic genes in BAT was not affected33. In
vitro, IRF3 overexpression decreased thermogenic markers in
white adipocytes, indicating that IRF3 is a negative modulator of
adipose tissue browning33. Herein, we confirm a regulatory role
of IRF3 in the control of Ucp1 expression in adipocytes, as Irf3
knockdown blunted LPS-mediated decrease in Ucp1 expression in
adipocytes. Moreover, ASK1 can directly phosphorylate IRF3 and
phosphorylation of the latter was blunted in ASK1 depleted white
adipocytes, indicating that ASK1 regulates Ucp1 expression IRF3-
dependently in white adipocytes. In addition, ASK1-mediated
IRF3 phosphorylation in vivo may also be partially regulated
via an indirect mechanism. Indeed, the ASK1 down-stream
mediators stress-activated protein kinase p38 and JNK are
involved in IRF3 phosphorylation/activation47,48.
Reduced oxygen consumption and blunted UCP1 protein
levels in BAT 12 h upon administration of the β3-adrenoreceptor
agonist CL316,243 was recently reported in adipocyte-specific
ASK1-deficient mice49. Such data indicate that ASK1 expression
specifically in adipocytes is involved in the acute regulation of
UCP1 in BAT. By contrast, our findings suggest that ASK1
expression in BAT has no major impact on UCP1 protein levels
in a more chronic setting, i.e. after cold stimulation for 7 days. Of
note, browning of WAT was not assessed in adipocyte-specific
ASK1 knockout mice in afore mentioned study49.
In conclusion, our study identifies a previously unknown role
for ASK1 in energy metabolism. We provided evidence that
adipocyte-specific ASK1 depletion promotes browning of adipose
tissue in HFD-fed mice thereby reducing obesity and glucose
intolerance. Thus, ASK1 may be a pharmacological target to
combat obesity and associated morbidities given its selective
impact on WAT browning.
Methods
Animals. Targeted embryonic stem (ES) cell clones with exon 14 (whose deletion
will lead to a frameshift) of ASK1 flanked by loxP sites and a FRT-flanked selection
cassette were bought from the European Conditional Mouse Mutagenesis Program
(EUCOMM). Morula aggregation for producing chimeric mice from ES cells (B6
background, TyrC+) and foster mothers (Tgv, TyrC-) was performed with the help
of Dr. Pawel Pelczar (Institute of Laboratory Animal Science, University of Zurich).
Subsequently, obtained chimeras were crossed with B6-albino mice (TyrC-). Off-
springs with successful germ-line transmission (black mice) were screened for the
presence of the inserted loxP sites by PCR. Mice heterozygous for floxed ASK1
were subsequently interbred to produce homozygous mutant mice. Subsequently,
the FRT flanked selection cassette was removed by breeding the floxed ASK1 mice
with Flp0 deleter mice50.
To obtain adipocyte-specific ASK1 depletion (ASK1Δadipo), homozygous ASK1
floxed mice without selection cassette were bred to mice that express the Cre enzyme
driven by the adipocyte-specific adiponectin promoter (C57BL/6; FVB-Tg(Adipoq-
Cre)1Evdr/J mice)51. Littermate mice with floxed ASK1 but absent Cre-recombinase
(Cre) expression were used as controls (ASK1F/F). To obtain myeloid-specific ASK1
depletion (ASK1Δmye), homozygous ASK1 floxed mice were bred to mice that
express the Cre enzyme driven by the myeloid-specific Lysozyme M-promoter
(C57BL/6;129-Lys<tm1(Cre)Ifo>) mice52. Littermate mice with floxed ASK1 but
absent Cre-recombinase (Cre) expression were used as controls (ASK1F/F).
Adipocyte-specific knockout mice were genotyped by PCR with primers amplifying
the Cre transgene (generating 250 bp Cre (Cre forward GCACTGATTTCGACCA
GGTT; Cre reverse CCCGGCAAAACAGGTAGTTA) and 324 bp control (actin
forward TGTTACCAACTGGGACGACA; actin reverse GAC ATGCAAGGAGT
GCAAGA) allele products) and ASK1 (generating 191 bp wild-type and 216 bp
“floxed” allele products (ASK1flox forward CCTCAGAGGAACTGAGCTGCCA;
ASK1flox reverse TCAGACCAAGGGCCAGAGAGA)). Myeloid specific knockout
mice were genotyped by PCR with primers amplifying the Cre transgene (generating
350 bp wild-type and 700 bp Cre allele products (Cre CCCAGAAATGCCAG
ATTACG; LysM forward CTTGGGCTGCCAGAATTTCTC; LysM reverse
TTACAGTCGGCCAGGCTGAC) and ASK1 (generating 191 bp wild-type and 216
bp “floxed” allele products). Adipocyte-specific ASK1-overexpressing mice were
generated in collaboration with the company PolyGene (Rümlang, Switzerland). The
cDNA of ASK1 was inserted into the Rosa26 locus together with the ubiquitous beta
actin promoter (CAG)31 and a loxP-flanked stop cassette (CAG-ASK1F/F). ASK1
overexpression in adipocytes was induced via Cre-lox mediated excision of the stop
cassette by breeding CAG-ASK1F/F mice to afore mentioned Adipoq-Cre mice
(CAGASK1+adipo). All mice were housed in a specific pathogen-free environment
on a 12-h-light-dark cycle (light on from 7 am to 7 pm) and fed ad libitum with
regular chow diet (ProvimiKliba, Kaiseraugst, Switzerland) or high fat diet (HFD)
(58 kcal% fat w/sucrose Surwit Diet, D12331, Research Diets). All protocols
conformed to the Swiss animal protection laws and were approved by the Cantonal
Veterinary Office in Zurich, Switzerland.
Western blotting. Tissues or cells were lysed in ice-cold lysis buffer containing
150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1 mM EGTA, 1% NP-40, 0.25% sodium
deoxycholate, 1 mM sodium pyrophosphate 1 mM sodium vanadate, 1 mM NaF,
10 mM sodium β-glycerolphosphate, 100 nM okadaic acid, 0.2 mM PMSF and a
1:1000 dilution of protease inhibitor cocktail (Sigma-Aldrich, Saint-Louis, MI,
USA). Protein concentration was determined using a BCA assay (Pierce, Rockford,
IL, USA). Equal amounts of protein were resolved by LDS-PAGE (4–12% gel;
NuPAGE, Invitrogen, Basel, Switzerland) and electro-transferred onto nitrocellu-
lose membranes (0.2 μm, BioRad, Reinach, Switzerland). Equal protein loading on
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membranes was checked by Ponceau S staining. Blots were blocked in tris-buffered
saline (50 mM Tris-HCl, 150 mM NaCl) containing 0.1% Tween (TBS-T) sup-
plemented with 5% non-fat dry milk. Membranes were then placed in a 50 ml
Falcon tube and incubated overnight at 4 °C with gentle rotation with the
respective primary antibody solutions. Antibody-antigen complexes were detected
by using the ECL system and detected with the Fuji LAS-3000 image reader
(Fujifilm, Tokyo, Japan). The following primary antibodies were used: UCP1, PA1-
24894 (ThermoFisher Scientific, Waltham, MA, USA; diluted 1:1000); Pgc1α, AB
3242 and Actin MAB1501 (Millipore, Darmstadt, Germany; diluted 1:5000); ASK1,
AB45178 (Abcam, Cambridge, UK; diluted 1:1000), pASK1, sc-109911 (Santa Cruz
Biotechnology, Dallas, TX, USA; diluted 1:200), pIRF3 29047 (Cell Signaling,
Danvers, MA, USA; diluted 1:1000), GAPDH, 10494-1-AP (Proteintech, Man-
chester, UK; diluted 1:1000).
Immunohistochemistry. Sections of inguinal adipose tissue were cut (4 µm),
deparaffinized, and rehydrated. Slides were incubated with 3% hydrogen peroxide
to block endogenous peroxidases. For antigen retrieval, slides were submerged in
0.01 mol/L sodium citrate (pH 6.0) and heated to 95–100 °C for 20-40 min. Slides
were incubated with 10% goat serum followed by incubation with anti-UCP1
primary antibody (PA1-24894 (Thermofisher Scientific, Waltham, MA, USA)
diluted 1:500 at 4° overnight. Primary antibody binding was detected with an anti-
rabbit horseradish peroxidase (HRP) Detection Reagent (Cell Signaling, Danvers,
MA, USA). Labeling was visualized with (DAB) (Cell Signaling). Slides were
counterstained with hematoxylin.
RNA extraction and quantitative reverse transcription-PCR (RT-PCR). Total
RNA was extracted with the RNAeasy Lipid Tissue Mini Kit (Qiagen, Hilden,
Germany). RNA concentration was determined spectrophotometrically using
NanoDrop® (Thermofisher). RNA (0.25–1 µg) was reverse transcribed with Pri-
meScript RT reagent kit using random hexamer primers (Takara, Kusatsu, Japan).
TaqMan system was used for real-time PCR amplification. Relative gene expression
was obtained after normalization to 18s RNA, using the formula 2−ΔΔcp. The
following primers/probes were used: Tnfα Mm00443258_m1, Il-6
Mm00446190_m1, Il-1β Mm0043422/8_m1, Mcp1 Mm00441242_m1, Il-10
Mm00439614_m1, F4/80 Mm00802529_m1, Ask1 Mm0043883_m1, 18 s 4352930,
Ucp1 Mm01244861_m1, Pgc1α Mm01208835_m1, Cidea Mm00432554_m1,
Prdm16 Mm00712556_m1 (Applied Biosystems, Rotkreuz, Switzerland).
Determination of circulating plasma levels. Plasma insulin was measured using
the Ultra-Sensitive Mouse Insulin ELISA Kit (Chrystal Chem, Downers Grove, IL,
USA). Plasma cytokine levels were determined using MSD technology (Meso Scale
Discovery, Gaithersburg, MD, USA). Plasma adiponectin levels were measured
with an ELISA kit (Axxora, San Diego, CA, USA). LPS was measured in blood
plasma by using the Limulus Amebocyte Lysate (LAL) Kit (Lonza, Visp, Switzer-
land) following the manufacturer’s instructions. Endotoxin levels are expressed as
arbitrary units.
Liver triglyceride measurement. Liver triglycerides were measured from 50mg of
liver tissue according to the method of Bligh and Dyer53 and quantified with an
enzymatic assay (Roche Diagnostics, Rotkreuz, Switzerland).
Chronic LPS infusion. Mice were anesthetized with isoflurane and an osmotic
mini-pump (Alzet Model 1004; Alza, Palo Alto, CA) was implanted into the
intraperitoneal cavity through a 3-mm incision in the abdominal wall. The mini-
pumps were either filled with saline (0.9% NaCl) or LPS from Escherichia coli (055:
B5, Sigma, St. Louis, MO) to infuse 300 µg/kg*day for 24 days.
Glucose and insulin tolerance test. For intraperitoneal glucose tolerance test
(ipGTT) mice were fasted overnight and for intraperitoneal insulin tolerance tests
(ipITT) for 3 h. Either glucose (2 g/kg body weight) or human recombinant insulin
(1.0 U/kg body weight) was injected intraperitoneally by a gavage needle (0.30 mm
(30 G) × 8mm; BD Micro-Fine, Becton Dickinson, France). Blood glucose con-
centration was measured with a Glucometer (Accu-Check Aviva; Roche Diag-
nostik, Rotkreuz, Switzerland) collected from the tail vein at 0, 15, 30, 45, 60, 90,
and 120 min.
Clamp studies. Hyperinsulinemic-euglycemic clamp studies were performed in
freely moving mice54. Mice were anesthetized with isofluoran and eye ointment
was applied to both eyes (Vitamin A, Bausch & Lomb Swiss AG, Switzerland). A
catheter (MRE 025, Braintree Scientific, Braintree, MA, USA) was inserted into the
right jugular vein and exteriorized at the neck. Five to seven days after the surgery,
clamp was performed in mice that have lost less than 10% of their pre-operative
weight. Insulin was infused at a constant rate (18 mU/kg*min) and steady state
glucose infusion rate was calculated once glucose infusion reached a more or less
constant rate for 15–20 min with blood glucose levels at 4–5 mmol/l. The glucose
disposal rate was calculated by dividing the rate of [3-3 H] glucose infusion by the
plasma [3-3 H] glucose specific activity. Endogenous glucose production during the
clamp was calculated by subtracting the glucose infusion rate from the glucose
disposal rate. In order to assess tissue specific glucose uptake, a bolus (10 μCi) of 2-
[1-14 C] deoxyglucose was administered via catheter at the end of the steady state
period. Blood was sampled 2, 15, 25, and 35 min after bolus delivery. Area under
the curve of disappearing plasma 2-[1-14C] deoxyglucose was used together with
tissue-concentration of phosphorylated 2-[1-14C] deoxyglucose to calculate glu-
cose uptake. Accumulation of 2-[1-14C] deoxyglucose was determined in an
aqueous tissue extract after homogenization. Phosphorylated 2-[1-14C] deox-
yglucose was separated by Poly-Prep columns (#731-6212, BioRad).
Metabolic cage analysis. After a stepwise adaptation to single caging, mice were
placed individually in air-tight cages designed for metabolic phenotyping in an
open-circuit indirect calorimetric system (PhenoMaster, TSE Systems, Bad Hom-
burg, Germany). The sampling interval for each cage was 2 min, with repetition
every 18 min. A total of 72 data points for food intake, O2 consumption, and CO2
production were recorded over a 24-h period. Locomotor activity data were
measured using a 2-dimensional infrared light-beam. Energy expenditure (EE) and
oxygen consumption (VO2) were calculated using the manufacturer’s software and
values were corrected for body mass.
Thermoneutrality. Single caged mice were put in a temperature and lightning
controlled climate chamber system (PhenoMaster, TSE Systems). The temperature
was then increased to 30 °C for 20 days.
Chronic cold-exposure and thermoneutrality. Single caged mice were put in a
temperature and lightning controlled climate chamber system (PhenoMaster, TSE
Systems). The temperature was then gradually lowered to 7 °C. On day 7 of the
cold-exposure, mice were sacrificed and organs were harvested.
Rectal temperature measurement. A digital thermometer (ama-digit ad 15th)
was used in combination with a stainless probe. The probe was inserted 2 cm into
the anal ducts of mice. Temperature was measured at 4 pm.
Bomb calorimetry. Faecal energy content was measured by bomb calorimetry by
the Mouse Metabolic Evaluation Facility in Lausanne, Switzerland. Briefly, faeces
was collected, dried to constant weight (0.001 g) at 60 °C, and energy content of
dried feces (kJ/g) was analyzed for each individual mouse using a bomb calorimeter
(IKA C200, Staufen, Germany).
Cell culture. The generation and characterization of immortalized subcutaneous
white pre-adipocytes was described previously25. All cells were seeded onto
collagen-coated plates and grown in Dulbecco’s modified Eagle’s medium (DMEM)
containing 25 mM glucose supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin (all from Invitrogen, Basel, Switzerland) (complete
medium, CM) prior to differentiation. Two days post-confluent, subcutaneous
white pre-adipocytes cells were treated with a mixture of methylisobutylxanthine
(500 μM), dexamethasone (1 μM), insulin (1.7 μM) and rosiglitazone (1 μM) in CM
to induce differentiation (day 0, D0). Two days later (D2), medium was changed to
high glucose culture medium containing insulin (0.5 μM). Subsequently culture
medium was replaced every other day until the day of experiment. Differentiated
subcutaneous cells were transfected with 100 nM of siRNA SMARTpools, siRNA
targeting ASK1 or non-targeting siRNA SMARTpools, control siRNA for 24 h, as
previously described for HepG2 cells55. LPS treatment was started 24 after
ASK1 siRNA transfection. For IRF3 knockdown, mature cells were reverse trans-
fected by Lipofectamine RNAiMAX (ThermoFisher Scientific) with 50 nM of a
pool of 4 different siRNA targeting Irf3 (LQ-041095-00-0005, Dharmacon) or ON-
TARGETplus Non-targeting Control Pool siRNA (D-001810-10-50, Dharmacon).
48 h post-transfection, cells were treated with LPS for 24 h. 18 h later, cells were
treated with 100 nM ISO for 6 h.
Vector generation. A total of 3 siRNA sequences predicted to target the ASK1 or
IRF3 protein were designed with the siDESIGN center tool from Dharmacon. The
knockdown efficiency of each construct was tested in vitro and the best candidate
sequence of both targets was converted into the relative shRNA and sub-cloned
down-stream the U6 promoter of the lentiviral vector pLL3.7 using HpaI (5′) and
XhoI (3′). As a control, we generated shRNA against luciferase (shLuc). pLV-
CMV-eGFP, pLV-CMV-ASK1 (wild-type) and pLV-CMV-ASK1-K716R (muta-
ted) vectors were created by Vector Builder Inc (Chicago, IL, USA).
Lentivirus production. In order to produce the relative lentiviruses, HEK-293LTV
cells (Cell Biolabs, San Diego, CA, USA) were initially plated into a p15 dish and
then transfected when ~ 90% confluent with 9 µg of pMD2G (envelop vector), 24
µg of pPAX2 (packaging vector) and 30 µg of the relative trans-vector in the
presence of 1 mg/ml of polyethylenamine (PEI). 12 h after transfection, media were
refreshed. 24 h later, media were collected and stored at 4 °C while the cells received
new media. This procedure was repeated 24 h later and then media for the same
lentivirus were pooled. After spinning at 2000 × g for 10 min at 4 °C to precipitate
cells debris, 5X PEG-IT Virus Precipitation Solution (SBI System Biosciences,
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Mountain View, CA, USA) was added to the media. After vortexing, media were
left at 4 °C overnight (at least 12 h). The day after, media were spun at 1500 × g for
30 min at 4 °C. Pellets (lentivirus particles) were suspended with PBS+ 25 mM
Hepes in 1/1000 of the initial volume of the pooled media. Aliquots were created
and stored at −80 °C. Lentivirus titers were biologically established by qPCR.
Lentivirus transduction. Lentiviral stocks were prepared as described above.
scWAT adipocytes were reverse transduced with shLuc or shASK1 (12.5 MOI),
with shLuc or shIRF3 (20 MOI) lentiviral particles in CM supplemented with
polybrene (8 μg/ml). After 6 h, medium was replaced to CM supplemented with
0.5 μM insulin and changed every other day until the day of experiment (Day 11).
For experiments overexpressing ASK1, mature cells were reverse transduced with
10 MOI of pLV-CMV-eGFP, pLV-CMV-ASK1 or pLV-CMV-ASK1-K716 in the
presence of polybrene (8 μg/ml). Cells were harvested 48 h after eGFP expression
was detected.
LPS treatment of mature subcutaneous adipocytes. Cells were differentiated as
described above for 6 to 7 days, or 11 days for virus transduced cells, and then
treated with 100 ng/ml LPS from Escherichia (coli 055: B5, Sigma) for 24 h. The
next day, cells were treated with 0.1 µM isoproterenol (Sigma) for 6 h. Subsequently
cells were immediately frozen at −80 °C until further processing.
ASK1 kinase assay. Recombinant IRF3 (1–2 µg; ab205216, Abcam) was incubated
in a reaction buffer (40 mM Tris pH 7.5, 20 mM MgCl2, 50 µM DTT, 200 µM ATP)
with or without active ASK1 (50 nM; V3881, Promega, Dübendorf, Switzerland) for
60 min at 30 °C. Total reaction volume was 20 µl. Reaction was stopped by the
addition of 20 µl 2x Laemmli sample buffer.
Data analysis. Data are presented as means ± SEM. Normally distributed data
were analyzed by unpaired two-tailed Student’s t test, one-way ANOVA with
Tukey or Newman-Keuls correction for multiple group comparisons or two-way
ANOVA with Bonferroni multiple comparisons. For non-parametric data the
Mann–Whitney test was used. All statistical tests were calculated using the
GraphPad Prism 8.0.0 (GraphPad Software, San Diego, CA, USA). P values < 0.05
were considered to be statistically significant. Power calculation analysis was not
performed. The evaluator was blinded to the identity of a specific sample as far as
the nature of the experiment allowed it.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available within the article or
its Supplementary Information files. All data are available from the corresponding author
upon reasonable request. The source data underlying all Figures and Supplementary
Figures are provided as a Source Data file.
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